Brugada syndrome cost-effectiveness of therapy

Revision as of 05:43, 15 March 2016 by WikiBot (talk | contribs) (Bot: Adding CME Category::Cardiology)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Brugada syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Brugada syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Examples of Type I Brugada Syndrome

Chest X Ray

Echocardiography or Ultrasound

Electrophysiologic Studies

Genetic Testing

Treatment

Treatment

Drugs to Avoid

Drugs to Preferably Avoid

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brugada syndrome cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brugada syndrome cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brugada syndrome cost-effectiveness of therapy

CDC on Brugada syndrome cost-effectiveness of therapy

Brugada syndrome cost-effectiveness of therapy in the news

Blogs on Brugada syndrome cost-effectiveness of therapy

Directions to Hospitals Treating Brugada syndrome

Risk calculators and risk factors for Brugada syndrome cost-effectiveness of therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS CME Category::Cardiology